BenevolentAI
cash runway to providing capital for key value in points cash runway capital allocation cash at cash burn of before working capital movements cash runway guidance assumes no future capital from licensing or collaboration agreements multiple assets at or close to key value in points fund phase i trial for ben in ulcerative colitis and commencement of phase trial in fund enabling work for ben and begin phase i trial in in progress balance of pipeline as well as fund enabling work of novel als asset to complete in continuous enhancement of the benevolent platform to support further collaborations business operations to support group activities sufficient inflection | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
March 2023
Slide
13 of 38
Related slides by other companies
Equillium
Investor Presentation
November 2023
milestones | Equillium
Equillium
Investor Presentation
December 2023
milestones | Equillium
Equillium
Investor Presentation
February 2024
milestones | Equillium
Equillium
Investor Presentation
August 2023
milestones | Equillium
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Investor Conference
January 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io